FY2030 Earnings Estimate for Aemetis Issued By HC Wainwright

Aemetis, Inc (NASDAQ:AMTX) – Equities researchers at HC Wainwright issued their FY2030 earnings estimates for shares of Aemetis in a research note issued to investors on Friday, March 13th. HC Wainwright analyst A. Dayal anticipates that the specialty chemicals company will post earnings of $3.05 per share for the year. The consensus estimate for Aemetis’ current full-year earnings is ($2.07) per share.

Several other equities analysts also recently weighed in on AMTX. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Aemetis in a research note on Wednesday, January 21st. Ascendiant Capital Markets lowered their target price on Aemetis from $21.00 to $20.00 and set a “buy” rating on the stock in a report on Wednesday, November 19th. Finally, Loop Capital set a $1.75 price target on Aemetis in a research note on Thursday. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $8.25.

Aemetis Price Performance

Shares of NASDAQ:AMTX opened at $2.29 on Monday. The business’s 50 day simple moving average is $1.55 and its 200-day simple moving average is $1.90. The firm has a market capitalization of $151.60 million, a price-to-earnings ratio of -1.72 and a beta of 2.61. Aemetis has a 12 month low of $1.22 and a 12 month high of $3.66.

Aemetis (NASDAQ:AMTX) last issued its earnings results on Thursday, March 12th. The specialty chemicals company reported ($0.24) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.28) by $0.04. The company had revenue of $43.31 million during the quarter, compared to analysts’ expectations of $72.07 million.

Hedge Funds Weigh In On Aemetis

Hedge funds have recently made changes to their positions in the business. Vanguard Group Inc. grew its stake in shares of Aemetis by 15.3% during the third quarter. Vanguard Group Inc. now owns 2,479,163 shares of the specialty chemicals company’s stock valued at $5,578,000 after acquiring an additional 329,760 shares in the last quarter. Geode Capital Management LLC lifted its position in shares of Aemetis by 5.0% in the 4th quarter. Geode Capital Management LLC now owns 693,453 shares of the specialty chemicals company’s stock worth $964,000 after buying an additional 33,286 shares during the last quarter. Marshall Wace LLP lifted its position in shares of Aemetis by 289.3% in the 4th quarter. Marshall Wace LLP now owns 559,754 shares of the specialty chemicals company’s stock worth $778,000 after buying an additional 415,978 shares during the last quarter. State Street Corp boosted its holdings in shares of Aemetis by 13.9% in the 4th quarter. State Street Corp now owns 260,299 shares of the specialty chemicals company’s stock valued at $362,000 after buying an additional 31,700 shares during the period. Finally, Jane Street Group LLC acquired a new position in shares of Aemetis in the 2nd quarter valued at about $634,000. Hedge funds and other institutional investors own 27.02% of the company’s stock.

Aemetis News Roundup

Here are the key news stories impacting Aemetis this week:

• Positive Sentiment: Management outlined an expected ~$32 million of incremental annual cash flow from an MVR (mechanical vapor recompression) upgrade at the ethanol plant — a clear operational catalyst for free cash flow and valuation upside. Aemetis outlines $32M annual cash flow target from MVR upgrade as biogas segment turns
• Positive Sentiment: Dairy RNG production is scaling (reported +61% YoY in Q4) and the biogas segment was described as turning profitable, supporting recurring cash flow and reduced reliance on commodity ethanol margins. Aemetis Reports Fourth Quarter and Full Year 2025 Results as Dairy RNG Platform Scales
• Neutral Sentiment: Q4 EPS beat the consensus modestly (loss of $0.24 vs. est. $0.28), which helped tone sentiment, but the company remains unprofitable on an EPS basis; management commentary from the earnings call gave more operational detail. Listen to Conference Call / Press Release
• Neutral Sentiment: Reported short‑interest figures in available summaries look erroneous (showing 0 shares and NaN changes); there’s no clear sign of elevated short pressure from reliable public data yet.
• Negative Sentiment: Revenue missed materially in Q4 — $43.3M reported vs. analysts’ ~$72.1M estimate — which is a near-term headwind and explains lingering skepticism despite operational positives. Aemetis (AMTX) Reports Q4 Loss, Misses Revenue Estimates

Aemetis Company Profile

Aemetis, Inc, headquartered in Cupertino, California, is a renewable fuels and renewable natural gas producer dedicated to decarbonizing the transportation sector. The company operates two primary business segments: Aemetis Advanced Fuels, which manufactures ethanol, biodiesel and sustainable aviation fuel using patented carbon capture and separation technology; and Aemetis RNG, which develops dairy-based renewable natural gas projects in California for pipeline injection and transportation use.

Since its incorporation in 2006, Aemetis has expanded its production footprint through organic growth and strategic acquisitions.